Secukinumab: A complete approach to psoriatic patients-Real-world evidence study

Dermatol Ther. 2021 Mar;34(2):e14815. doi: 10.1111/dth.14815. Epub 2021 Feb 17.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antibodies, Monoclonal, Humanized*
  • Arthritis, Psoriatic* / drug therapy
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab